Similar articles

• [Plasma levels of beta-thromboglobulin and platelet factor 4 in clinical conditions (author's transl)].

  Motomiya T, Yahara Y, Onozawa Y, Watanabe C, Tomura S, Sano T, Yamazaki H. Motomiya T, et al. Nihon Ketsueki Gakkai Zasshi. 1980 Oct;43(5):864-70. Nihon Ketsueki Gakkai Zasshi. 1980. PMID: 6165212 Japanese. No abstract available.
• [Clinical applications of beta-thromboglobulin and platelet factor 4 radioimmune assays (author's transl)].

  Lokiec F, Najean Y. Lokiec F, et al. Nouv Presse Med. 1980 Oct 18;9(38):2833-4, 2837-8. Nouv Presse Med. 1980. PMID: 6160454 French.
• [Determination of platelet activation products (platelet factor IV and beta-thromboglobulin) in a group of workers with long-term exposure to carbon disulfide].

  Craveri A, Lanfredini M, Tornaghi G, Frangione A, Milella AM, Ranieri R, Tonali M, Gatti L, Franco G, Moia M. Craveri A, et al. G Clin Med. 1980 Nov;61(11):812-21. G Clin Med. 1980. PMID: 6165639 Italian. No abstract available.
• [Beta-thromboglobulin and platelet factor 4. A review].

  Arocha-Piñango CL, Ojeda A. Arocha-Piñango CL, et al. Sangre (Barc). 1983;28(2):199-209. Sangre (Barc). 1983. PMID: 6192508 Review. Spanish. No abstract available.
• Platelet markers of thromboembolic disease.

  Wohl H. Wohl H. West J Med. 1981 Jul;135(1):19-24. West J Med. 1981. PMID: 6167074 Free PMC article. Review.